Elevated Cardiovascular Risk In ARDs Patients with ARDs face heightened CV risk due to multiple factors: persistent inflammation, frequent use of glucocorticoids and NSAIDs, and higher prevalence of cardiometabolic conditions such as obesity, type 2 diabetes, and hypertension
The cohort included fourteen men with baseline IGF-1 concentrations below 200 ng/mL
Vishal Khetpal is a fellow in cardiovascular disease in the Brown University Cardiology Fellowship Program
If you need the most aggressive weight loss intervention available, retatrutide is it
The adherence picture adds another wrinkle
In cases of confirmed deficiency, treatment may support: Reduced fatigue Improved energy levels Better concentration For individuals without deficiency, effects may be less noticeable